- Home
- KLRS vs ASRV Comparison
KLRS vs ASRV Comparison
Compare KLRS & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- ASRV
- Stock Information
- Founded
- KLRS 2019
- ASRV 1983
- Country
- KLRS United States
- ASRV United States
- Employees
- KLRS N/A
- ASRV N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- ASRV Major Banks
- Sector
- KLRS Health Care
- ASRV Finance
- Exchange
- KLRS Nasdaq
- ASRV Nasdaq
- Market Cap
- KLRS 46.0M
- ASRV 49.4M
- IPO Year
- KLRS N/A
- ASRV N/A
- Fundamental
- Price
- KLRS $2.56
- ASRV $3.05
- Analyst Decision
- KLRS Buy
- ASRV
- Analyst Count
- KLRS 1
- ASRV 0
- Target Price
- KLRS N/A
- ASRV N/A
- AVG Volume (30 Days)
- KLRS 45.1K
- ASRV 12.0K
- Earning Date
- KLRS 08-13-2025
- ASRV 10-21-2025
- Dividend Yield
- KLRS N/A
- ASRV 3.93%
- EPS Growth
- KLRS N/A
- ASRV N/A
- EPS
- KLRS N/A
- ASRV 0.22
- Revenue
- KLRS N/A
- ASRV $51,581,000.00
- Revenue This Year
- KLRS N/A
- ASRV N/A
- Revenue Next Year
- KLRS N/A
- ASRV N/A
- P/E Ratio
- KLRS N/A
- ASRV $13.83
- Revenue Growth
- KLRS N/A
- ASRV 13.95
- 52 Week Low
- KLRS $2.14
- ASRV $2.03
- 52 Week High
- KLRS $24.15
- ASRV $3.42
- Technical
- Relative Strength Index (RSI)
- KLRS 49.38
- ASRV 57.27
- Support Level
- KLRS $2.37
- ASRV $2.90
- Resistance Level
- KLRS $2.58
- ASRV $3.14
- Average True Range (ATR)
- KLRS 0.18
- ASRV 0.09
- MACD
- KLRS 0.01
- ASRV 0.02
- Stochastic Oscillator
- KLRS 64.32
- ASRV 70.59
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.